BRIACELL THERAPEUTICS CORP. (BCTX) Free cash flow 2024–2026
BRIACELL THERAPEUTICS CORP. (BCTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.8MFY2026 · since FY2024: -$24.6M → -$28.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$28.8M | — |
| FY2024 | -$24.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTX financial trends
BCTX RevenueBCTX Net incomeBCTX Net marginBCTX Gross profitBCTX Gross marginBCTX Operating incomeBCTX Operating marginBCTX Operating cash flowBCTX Capital expendituresBCTX Return on equityBCTX Stock buybacksBCTX Dividends paidBCTX Total assetsBCTX Total liabilitiesBCTX Shareholders’ equityBCTX overview →